Harbour Investments, Inc. Immunity Bio, Inc. Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$5.67 - $10.18 $7,376 - $13,244	-1,301 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $9 - $14	1 Added 0.08%	1,301 $13,000
Q1 2021 Aug 17, 2021	BUY	$12.83 - $42.25 $16,666 - $54,882	1,299 Added 129900.0%	1,300 $31,000
Q1 2021 May 12, 2021	BUY	$12.83 - $42.25 $12 - $42	1 New	1 $0

235

82.4M

1.02M

2.25M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $989M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.